Morgan Stanley’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68B | Buy |
|
|||||
|
2025
Q1 | $1.28B | Buy |
|
|||||
|
2024
Q4 | $1.01B | Sell |
|
|||||
|
2024
Q3 | $1.16B | Sell |
|
|||||
|
2024
Q2 | $1.16B | Sell |
|
|||||
|
2024
Q1 | $1.34B | Sell |
|
|||||
|
2023
Q4 | $2.6B | Buy |
|
|||||
|
2023
Q3 | $1.31B | Buy |
|
|||||
|
2023
Q2 | $1.46B | Buy |
|
|||||
|
2023
Q1 | $1.71B | Sell |
|
|||||
|
2022
Q4 | $1.95B | Sell |
|
|||||
|
2022
Q3 | $2.02B | Sell |
|
|||||
|
2022
Q2 | $2.17B | Sell |
|
|||||
|
2022
Q1 | $2.09B | Sell |
|
|||||
|
2021
Q4 | $2.24B | Sell |
|
|||||
|
2021
Q3 | $2.07B | Buy |
|
|||||
|
2021
Q2 | $2.08B | Buy |
|
|||||
|
2021
Q1 | $2.1B | Buy |
|
|||||
|
2020
Q4 | $1.19B | Buy |
|
|||||
|
2020
Q3 | $394M | Buy |
|
|||||
|
2020
Q2 | $301M | Buy |
|